Ignite Creation Date:
2025-12-24 @ 3:52 PM
Ignite Modification Date:
2026-01-06 @ 11:08 PM
Study NCT ID:
NCT06065592
Status:
UNKNOWN
Last Update Posted:
2023-10-06
First Post:
2023-09-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms
Sponsor:
Lebanese University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
| None | Solid Tumor | View |
| None | Thromboembolism | View |
| None | Cardiovascular Diseases | View |
| None | Immune System Diseases | View |
| None | Inflammatory Diseases | View |
| None | Colon Cancer | View |
| None | Breast Cancer | View |
| None | Prostate Cancer | View |
| None | Hepatocellular Carcinoma | View |
| None | Lung Cancer | View |
| None | Chemotherapy | View |
| None | Immunotherapy | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | cancer | View |
| None | thromboembolism | View |
| None | cardiovascular | View |
| None | immune cells | View |
| None | immunotherapy | View |
| None | chemotherapy | View |
| None | inflammation | View |
| None | gene polymorphism | View |
| None | biomarker | View |
| None | LncRNA | View |
| None | Palbociclib | View |
| None | Rivaroxaban | View |
| None | blood coagulation | View |